US Tech 100

19,233.60

-0.73%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
AMEX
Mallinckrodt plc (MNK)
Mallinckrodt plc (MNK) News

MNK

Mallinckrodt (MNK)

Mallinckrodt plc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:MNK

1 2 Next >>

Date	Time	Source	Headline	Symbol	Company
11/14/2024	9:05AM	PR Newswire (US)	Mallinckrodt to Present at Jefferies London Healthcare Conference	AMEX:MNK	Mallinckrodt plc
11/05/2024	6:45AM	PR Newswire (US)	Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance	AMEX:MNK	Mallinckrodt plc
10/30/2024	6:50AM	PR Newswire (US)	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting	AMEX:MNK	Mallinckrodt plc
10/10/2024	6:52AM	PR Newswire (US)	Mallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE™ DS Delivery System in U.S. Hospitals	AMEX:MNK	Mallinckrodt plc
09/17/2024	6:50AM	PR Newswire (US)	Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector	AMEX:MNK	Mallinckrodt plc
09/03/2024	3:45AM	PR Newswire (US)	THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)	AMEX:MNK	Mallinckrodt plc
08/06/2024	6:45AM	PR Newswire (US)	Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year Guidance	AMEX:MNK	Mallinckrodt plc
08/06/2024	6:35AM	PR Newswire (US)	Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S.	AMEX:MNK	Mallinckrodt plc
08/05/2024	7:00AM	PR Newswire (US)	Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million	AMEX:MNK	Mallinckrodt plc
08/05/2024	7:00AM	PR Newswire (US)	Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million	AMEX:MNK	Mallinckrodt plc
08/01/2024	8:59AM	PR Newswire (US)	Mallinckrodt to Report Earnings Results for Second Quarter 2024	AMEX:MNK	Mallinckrodt plc
08/29/2023	7:22AM	IH Market News	Tuesday’s Wall Street Highlights: Alphabet, Verizon, Joann, Intel, Catalent, and more	AMEX:MNK	Mallinckrodt plc
08/28/2023	4:46AM	PR Newswire (US)	Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations	AMEX:MNK	Mallinckrodt plc
08/28/2023	12:17AM	PR Newswire (US)	Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations	AMEX:MNK	Mallinckrodt plc
08/23/2023	8:32AM	PR Newswire (US)	Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan	AMEX:MNK	Mallinckrodt plc
08/23/2023	8:22AM	PR Newswire (US)	Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan	AMEX:MNK	Mallinckrodt plc
08/09/2023	6:45AM	PR Newswire (US)	Mallinckrodt plc Reports Second Quarter 2023 Financial Results and Reaffirms Full Year Guidance	AMEX:MNK	Mallinckrodt plc
06/15/2023	6:52AM	PR Newswire (US)	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the European Association for the Study of the Liver (EASL) Congress 2023	AMEX:MNK	Mallinckrodt plc
06/13/2023	2:30AM	PR Newswire (US)	Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients	AMEX:MNK	Mallinckrodt plc
06/01/2023	6:52AM	PR Newswire (US)	Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at the American Transplant Congress (ATC) 2023	AMEX:MNK	Mallinckrodt plc
05/09/2023	6:45AM	PR Newswire (US)	Mallinckrodt plc Reports First Quarter 2023 Financial Results and Reaffirms Full Year Guidance	AMEX:MNK	Mallinckrodt plc
05/08/2023	6:52AM	PR Newswire (US)	Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023	AMEX:MNK	Mallinckrodt plc
05/05/2023	6:52AM	PR Newswire (US)	Mallinckrodt Recognized as Industry Innovator at National Organization for Rare Disorders (NORD) 2023 Rare Impact Awards	AMEX:MNK	Mallinckrodt plc
04/28/2023	8:00AM	Business Wire	Buxton Helmsley Issues Letter to Mallinckrodt Plc. Regarding Failure to Address Evidential Multibillion-Dollar Asset Value Depreciation Expense Concealment Scheme	AMEX:MNK	Mallinckrodt plc
04/24/2023	6:45AM	PR Newswire (US)	Mallinckrodt to Report Earnings Results for First Quarter 2023	AMEX:MNK	Mallinckrodt plc
04/10/2023	6:53AM	PR Newswire (US)	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the National Kidney Foundation (NKF) 2023 Spring Clinical Meeting (SCM)	AMEX:MNK	Mallinckrodt plc
03/21/2023	6:53AM	PR Newswire (US)	Mallinckrodt to Present New Retrospective Data on Effect of Acthar® Gel (Repository Corticotropin Injection) to Reduce Corticosteroid Use and Burden for Advanced Sarcoidosis at the Academy of Managed Care Pharmacy (AMCP) 2023 Annual Meeting	AMEX:MNK	Mallinckrodt plc
03/09/2023	3:00AM	PR Newswire (US)	Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)	AMEX:MNK	Mallinckrodt plc
02/28/2023	6:45AM	PR Newswire (US)	Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance	AMEX:MNK	Mallinckrodt plc
02/16/2023	8:03AM	PR Newswire (US)	Mallinckrodt to Present at Cowen's 43rd Annual Health Care Conference	AMEX:MNK	Mallinckrodt plc